Myocardial revascularization for the treatment of post-ischemic heart failure

Domenico Pagano, Robert S. Bonser, Paolo G. Camici

Research output: Contribution to journalArticlepeer-review


Heart failure due to coronary artery disease is a major public health problem. Medical treatment ameliorates symptoms and prognosis, although mortality remains high. Heart failure occurs when a sizeable number of myocytes do not contract. This may be due to irreversible myocyte loss (infarct) and/or dysfunctional but viable myocytes (hibernating), which can resume function following coronary artery bypass surgery. The presence of hibernating myocardium can be predicted by noninvasive nuclear imaging using both single photon (SPECT) and positron emission tomography, and also by stress echocardiography. A number of uncontrolled studies have demonstrated a promising role for coronary artery bypass surgery in patients with heart failure in whom a substantial amount of hibernating myocardium is present. These findings, particularly the magnitude of the benefits reported, justify the need for a randomized trial in this patient population. Curr Opin Cardiol 1999, 14:506-509

Original languageEnglish
Pages (from-to)506-509
Number of pages4
JournalCurrent Opinion in Cardiology
Issue number6
Publication statusPublished - 1999

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Myocardial revascularization for the treatment of post-ischemic heart failure'. Together they form a unique fingerprint.

Cite this